Combination of inhibition of neuraminidase and acetylcholinesterase in humans may prove to be beneficial in the management of neurological disorders like Alzheimer’s disease (Khunnawutmanotham et al., 2024). Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.